In contrast, mutations and amplifications of receptor tyrosine kinase (RTK) genes (EGFR, PDGFRa, KIT, MET), PTEN loss, and telomerase reverse transcriptase (TERT) promoter mutations occur late in the development of GBM [11]. The gene discussed is TERT; the disease is glioblastoma.